Tvardi Therapeutics, Inc.(TVRD US)
$1.39-0.021.42%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 22.9 | 37.9 | 20.7 | 19.9 | |||||
| Short Term Investments | - | - | 10.1 | 5.1 | |||||
| Cash and Short Term Investments | 22.9 | 37.9 | 30.8 | 25.0 | |||||
| Net Receivables | 4.0 | 4.5 | - | - | |||||
| Inventory | - | 0.9 | - | - | |||||
| Other Current Assets | -4.0 | - | - | 0.3 | |||||
| Total Current Assets | 26.2 | 43.8 | 31.5 | 25.3 | |||||
| Property, Plant & Equipment | 0.4 | - | 0.2 | 0.2 | |||||
| Long Term Investments | 1.5 | - | - | - | |||||
| Other Non-Current Assets | -1.5 | - | 0.0 | 0.0 | |||||
| Total Non-Current Assets | 0.8 | - | 0.5 | 0.5 | |||||
| Total Assets | 27.0 | 43.8 | 32.1 | 25.8 | |||||
| Account Payables | 1.6 | 1.4 | 3.2 | 4.6 | |||||
| Short Term Debt | - | - | - | - | |||||
| Deferred Revenue | - | - | - | - | |||||
| Other Current Liabilities | 0.9 | 2.0 | 1.3 | 0.7 | |||||
| Total Current Liabilities | 3.3 | 4.0 | 11.0 | 11.3 | |||||
| Long Term Debt | - | 44.4 | - | - | |||||
| Other Non-Current Liabilities | 85.5 | - | - | - | |||||
| Total Non-Current Liabilities | 85.8 | 44.4 | 0.1 | 0.1 | |||||
| Total Liabilities | 89.1 | 48.4 | 11.1 | 11.3 | |||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | |||||
| Retained Earnings | -62.8 | -755.6 | -110.5 | -117.3 | |||||
| Total Stockholders Equity | -62.1 | -4.6 | 20.9 | 14.5 | |||||
| Total Liabilities and Equity | 27.0 | 43.8 | 32.1 | 25.8 | |||||
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 22.9 | 37.9 | 20.7 | 19.9 | |||||
| Short Term Investments | - | - | 10.1 | 5.1 | |||||
| Cash and Short Term Investments | 22.9 | 37.9 | 30.8 | 25.0 | |||||
| Net Receivables | 4.0 | 4.5 | - | - | |||||
| Inventory | - | 0.9 | - | - | |||||
| Other Current Assets | -4.0 | - | - | 0.3 | |||||
| Total Current Assets | 26.2 | 43.8 | 31.5 | 25.3 | |||||
| Property, Plant & Equipment | 0.4 | - | 0.2 | 0.2 | |||||
| Long Term Investments | 1.5 | - | - | - | |||||
| Other Non-Current Assets | -1.5 | - | 0.0 | 0.0 | |||||
| Total Non-Current Assets | 0.8 | - | 0.5 | 0.5 | |||||
| Total Assets | 27.0 | 43.8 | 32.1 | 25.8 | |||||
| Account Payables | 1.6 | 1.4 | 3.2 | 4.6 | |||||
| Short Term Debt | - | - | - | - | |||||
| Deferred Revenue | - | - | - | - | |||||
| Other Current Liabilities | 0.9 | 2.0 | 1.3 | 0.7 | |||||
| Total Current Liabilities | 3.3 | 4.0 | 11.0 | 11.3 | |||||
| Long Term Debt | - | 44.4 | - | - | |||||
| Other Non-Current Liabilities | 85.5 | - | - | - | |||||
| Total Non-Current Liabilities | 85.8 | 44.4 | 0.1 | 0.1 | |||||
| Total Liabilities | 89.1 | 48.4 | 11.1 | 11.3 | |||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | |||||
| Retained Earnings | -62.8 | -755.6 | -110.5 | -117.3 | |||||
| Total Stockholders Equity | -62.1 | -4.6 | 20.9 | 14.5 | |||||
| Total Liabilities and Equity | 27.0 | 43.8 | 32.1 | 25.8 | |||||